Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Melanin and melanocytes contribute to the brown pigmentation in stasis dermatitis.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.